Skip to content
Companies

Integrity Labs

PCR testing for complex infectious diseases

Raised to date

$15M

of $30M offered across 1 Form D filing

Still open
$15M
Investors
7
Last filed
Mar 21, 2025

About

Integrity Laboratories, Inc. is a pioneering biotechnology company committed to revolutionizing the management of infectious diseases through high-complexity clinical diagnostics. By offering cutting-edge molecular diagnostic testing solutions, the company strives to enhance the speed and accuracy of infectious disease detection and treatment across the healthcare landscape.

Integrity Laboratories stands out for its intercept PCR™ platform, which delivers rapid diagnostic results using non-invasive techniques.

Funding

  • EquityFiled Mar 21, 2025Form D
    $15M/ $30M

Product

Intercept PCR™ Platform

Molecular Diagnostics

The intercept PCR™ platform is an advanced molecular diagnostic testing solution that facilitates same-day and next-day results for complex infectious diseases. Its non-invasive methodology streamlines the diagnostic process, significantly enhancing patient care.

  • Rapid turnaround times (STAT and next-day results)
  • High-fidelity testing with over 99% specificity
  • Ability to differentiate polymicrobial specimens

Built for

Healthcare providers, healthcare systems, and insurance networks

People on file